Back to Search Start Over

Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival.

Authors :
Georgakopoulou VE
Zygouris E
Papalexis P
Gkoufa A
Damaskos C
Pierrakou A
Mantzouranis K
Chlapoutakis S
Aravantinou-Fatorou A
Sklapani P
Trakas N
Janinis J
Dahabreh J
Spandidos DA
Source :
Oncology letters [Oncol Lett] 2022 Jul 15; Vol. 24 (3), pp. 313. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Publication Year :
2022

Abstract

Pulmonary carcinoid tumors are rare, low-grade malignant tumors that constitute 1-2% of all lung tumors. The present study aimed to describe the simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and determine their association with survival rates. For this purpose, 108 patients with resected carcinoid lung tumors were followed-up for 96 months and analyzed for simultaneous pathological findings in biopsy specimens. Among these, simultaneous pathological findings were found in 82 patients. The association between these findings and patient survival rates was evaluated. Atelectasis was a simultaneous finding in 52.4% of the patients, desquamative interstitial pneumonia (DIP) in 13.4%, emphysema in 24.4% and bronchiectasis in 9.8%. The survival rate was 100% for the patients with atelectasis, 81.8% for the patients with DIP, 90% for the patients with emphysema and 75% for the patients with bronchiectasis (P<0.05). According to the univariate analysis, the type of carcinoid was associated with patient survival with better survival rates for patients with typical carcinoids, while age, sex, stage and simultaneous pathological findings were not associated with patient survival. On the whole, there was a statistically significant difference in the survival rates of patients with resected lung carcinoids with different simultaneous pathological findings. However, further studies are warranted to assess the role of these findings in the survival of these patients.<br />Competing Interests: DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.<br /> (Copyright: © Georgakopoulou et al.)

Details

Language :
English
ISSN :
1792-1082
Volume :
24
Issue :
3
Database :
MEDLINE
Journal :
Oncology letters
Publication Type :
Academic Journal
Accession number :
35949610
Full Text :
https://doi.org/10.3892/ol.2022.13433